Dor Biopharma, Inc. (DORB)

DOR BioPharma, Inc. engages in the research and development of oral therapeutic products in the United States and internationally.

Detailed Quote for DOR BioPharma Inc. (DORB)

Total Income, Quarterly

Profit margin

Net income

Revenue / Net income

Short Term Long Term

Accounts payable

31 Dec, 07	31 Mar, 08	30 Jun, 08	30 Sep, 08
1194000	1103000	1532000	1641000

Chart

Cash and cash equivalents

31 Dec, 07	31 Mar, 08	30 Jun, 08	30 Sep, 08
2220000	1881000	1078000	686000

Chart

Net receivables

31 Dec, 07	31 Mar, 08	30 Jun, 08	30 Sep, 08
98000	66000	100000	205000

Chart

Inventory

31 Dec, 07	31 Mar, 08	30 Jun, 08	30 Sep, 08
-	-	-	83000

Chart

Other current assets

31 Dec, 07	31 Mar, 08	30 Jun, 08	30 Sep, 08
119000	79000	176000	129000

Chart

Property plant and equipment

31 Dec, 07	31 Mar, 08	30 Jun, 08	30 Sep, 08
26000	25000	24000	22000

Chart

Intangible assets

31 Dec, 07	31 Mar, 08	30 Jun, 08	30 Sep, 08
1321000	1331000	1388000	1412000

Chart

Short Term Long Term

« Donini, Inc

Doral Finl Corp Mips Ser »

Social Bookmarking

Research Report

Hotstocked.com has a complete research report available for DORB stock. Download DORB report.

Research Report

Get the full report for FREE

Date:	Sep 2, 2008
Price:	Free
Pages:	5
Document Type:	Adobe Acrobat Reader
	Download DORB report

Example preview:

Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments

Related Tags

Featured Videos

Hot Green Energy Stock from China

From: OTC Journal
Added: 16 Sep, 2008

You aren't logged in Log in Register

Home > Companies > Dor Biopharma, Inc.

Dor Biopharma, Inc. (DORB)

More

Related Tags

Featured Videos